文献速递消化、代谢与肾脏急症复苏、休克与脓毒症

急诊疑似上消化道出血患者内镜前风险评分预测高危Forrest病变的比较

Comparison of pre-endoscopic risk scores for identifying high-risk Forrest lesions in emergency department patients with suspected upper gastrointestinal bleeding.
PubMed 文献 · Am J Emerg Med · 2026-08-16
一句话结论在急诊疑似上消化道出血患者中,CHAMPS评分预测高危Forrest病变的判别力最佳(AUC 0.889),优于Glasgow-Blatchford等评分。

这项前瞻性多中心队列研究纳入571例因疑似上消化道出血接受内镜的成人患者,比较CHAMPS、Glasgow-Blatchford、AIMS65、内镜前Rockall、HAS-BLED、ATRIA、ORBIT、VTE-BLEED和HEMORR₂HAGES预测高危Forrest病变(Ia-IIb)的性能。199例(34.9%)存在高危病变。CHAMPS的AUC为0.889(95%CI 0.860-0.916),显著优于Glasgow-Blatchford(AUC 0.831,p=0.001);在最佳截断值≥2时敏感度72.9%、特异度94.9%。作者认为CHAMPS可作为现有内镜前风险分层的补充而非替代,抗凝相关出血风险评分对急性内镜风险预测价值有限。

要点

  • CHAMPS预测高危Forrest病变的AUC为0.889(95%CI 0.860-0.916),在所有评估评分中最佳。
  • CHAMPS在最佳截断值≥2时:敏感度72.9%、特异度94.9%、阳性预测值88.4%、阴性预测值86.7%。
  • CHAMPS显著优于Glasgow-Blatchford评分(AUC 0.831,p=0.001),且在抗凝与非抗凝患者中均表现最佳。
  • 多变量分析中,较低血红蛋白、较高血尿素氮、较低收缩压、较高心率及较大年龄与高危Forrest病变独立相关。
  • 将CHAMPS加入基线临床模型使交叉验证AUC从0.804升至0.898,Brier评分从0.165降至0.109。

适用人群与场景

  • 因疑似上消化道出血接受上消化道内镜的成人患者(前瞻性多中心队列)。

诊断标准与关键阈值

  • 高危内镜发现定义为Forrest Ia-IIb;低危发现定义为Forrest IIc-III。
  • CHAMPS预测高危Forrest病变的最佳截断值为≥2。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:前瞻性多中心队列研究;样本量571例;高危Forrest病变199例(34.9%)。
  • 主要终点:CHAMPS预测高危Forrest病变AUC 0.889(95%CI 0.860-0.916),优于Glasgow-Blatchford(AUC 0.831,p=0.001)。
  • CHAMPS截断值≥2时敏感度72.9%、特异度94.9%、阳性预测值88.4%、阴性预测值86.7%。
  • 高危组较低危组年龄更大、血流动力学更不稳定、血红蛋白更低、血尿素氮更高、输血需求更多、ICU入住率更高、死亡率更高。
  • 多变量分析:较低血红蛋白、较高血尿素氮、较低收缩压、较高心率、较大年龄与高危Forrest病变独立相关。
  • CHAMPS加入基线临床模型后交叉验证AUC由0.804升至0.898,Brier评分由0.165降至0.109。
  • CHAMPS在抗凝与非抗凝患者中均为表现最佳的评分。

证据类型、等级与局限

  • 证据类型:前瞻性多中心队列研究。
  • 局限:原文指出需在不同急诊科环境中进一步验证后才能更广泛地临床使用;预测高危内镜征象应作为现有内镜前UGIB风险分层的补充而非替代。

对床旁实践的改变

  • 对急诊疑似上消化道出血患者,可考虑用CHAMPS评分(截断值≥2)辅助识别高危Forrest病变,但原文强调其应作为现有风险分层的补充而非替代。
  • 传统上消化道出血评分(如Glasgow-Blatchford)仍具临床价值;抗凝相关出血风险评分对急性内镜风险预测价值有限。
  • 原文指出需在不同急诊科环境中进一步验证后方可更广泛临床使用。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Early risk stratification in suspected upper gastrointestinal bleeding may help guide admission decisions, monitoring, and timing of endoscopy in the emergency department. Although several pre-endoscopic scores are widely used, their ability to predict high-risk endoscopic findings remains incompletely defined. This study aimed to compare the performance of established pre-endoscopic upper gastrointestinal bleeding scores and anticoagulation-related bleeding risk scores for predicting high-risk Forrest findings.

METHODS: This prospective multicentre cohort study included adult patients who underwent upper gastrointestinal endoscopy for suspected upper gastrointestinal bleeding. The primary outcome was high-risk endoscopic findings, defined as Forrest Ia-IIb. Low-risk findings were defined as Forrest IIc-III. We compared the performance of CHAMPS, Glasgow-Blatchford score, AIMS65, pre-endoscopic Rockall, HAS-BLED, ATRIA, ORBIT, VTE-BLEED, and HEMORR₂HAGES using receiver operating characteristic analysis. Multivariable logistic regression, calibration assessment, 10-fold cross-validated modelling, and Brier score were used to evaluate incremental discriminatory contribution beyond a baseline clinical model.

RESULTS: A total of 571 patients were included, of whom 199 patients (34.9%) had high-risk Forrest findings. Patients with high-risk findings were older and had greater haemodynamic instability, lower haemoglobin, higher blood urea nitrogen, greater transfusion requirement, higher intensive care unit admission, and higher mortality than those with low-risk findings. Among all evaluated scores, CHAMPS had the best overall performance for predicting high-risk endoscopic findings, with an AUC of 0.889 (95% CI: 0.860-0.916). At the optimal cut-off of ≥2, CHAMPS achieved 72.9% sensitivity, 94.9% specificity, 88.4% positive predictive value, and 86.7% negative predictive value. CHAMPS significantly outperformed the Glasgow-Blatchford score (AUC 0.831; p = 0.001). In multivariable analysis, lower haemoglobin, higher blood urea nitrogen, lower systolic blood pressure, higher heart rate, and older age were independently associated with high-risk Forrest findings. Adding CHAMPS to the baseline clinical model produced the greatest incremental improvement, increasing the cross-validated AUC from 0.804 to 0.898 and reducing the Brier score from 0.165 to 0.109. CHAMPS remained the best-performing score in both anticoagulated and non-anticoagulated patients.

CONCLUSION: In patients undergoing endoscopy for suspected upper gastrointestinal bleeding, CHAMPS showed stronger discrimination for high-risk Forrest findings than the other evaluated scores. Prediction of high-risk endoscopic stigmata should be considered complementary to existing pre-endoscopic UGIB risk stratification rather than a replacement for established risk scores. Conventional upper gastrointestinal bleeding scores remained clinically useful, whereas anticoagulation-related bleeding risk scores showed more limited value for acute endoscopic risk prediction. Additional validation in different emergency department settings is needed before broader clinical use.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Önür A, Ahmed SA, Toker İ, et al. Comparison of pre-endoscopic risk scores for identifying high-risk Forrest lesions in emergency department patients with suspected upper gastrointestinal bleeding. Am J Emerg Med. 2026. PMID: 42632219. doi:10.1016/j.ajem.2026.08.008

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。